Baloxavir (S-033447) is a novel small-molecule inhibitor that selectively targets the PA subunit of the influenza virus polymerase, acting via cap-dependent endonuclease inhibition. It is widely used in antiviral research for both in vitro mechanistic studies and in vivo efficacy models, supporting the development of novel anti-influenza therapeutics.